Evidence map›Paper›PMID 20204599›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2011

The hormonal profile of hip fracture female patients differs from community-dwelling peers over a 1-year follow-up period.

A R Cappola, W G Hawkes, N Blocher, J Yu-Yahiro, D Orwig, L Fredman, R R Miller, J M Guralnik, J Magaziner

Abstract read
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  3. Article
  4. Systemic Bone Loss After Fracture.Clinical reviews in bone and mineral metabolism · 2018
    Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

A R CappolaDivision of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, 764 CRB, 415 Curie Blvd., Philadelphia, PA 19104, USA. acappola@mail.med.upenn.edu
W G Hawkes
N Blocher
J Yu-Yahiro
D Orwig
L Fredman
R R Miller
J M Guralnik
J Magaziner
University of Maryland, Baltimore · USUniversity of Maryland, College Park · USBoston University · USEinstein Medical Center Philadelphia · USE.ON (Germany) · DEMedStar Union Memorial Hospital · USUniversity of Pennsylvania · US

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Sequelae of Hip Fracture in Men: An Epidemiologic StudyR37AG009901 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI MAGAZINER, JAY · 1992 to 2018
$11.3M
Pathogenesis of physical disability in Aging womenR37AG019905 · NIA · JOHNS HOPKINS UNIVERSITY · PI FRIED, LINDA P · 2001 to 2010
$9.0M
Androgens, Myostatin, and Sarcopenia in Older WomenK23AG019161 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CAPPOLA, ANNE R · 2002 to 2006
$676k
WOMEN'S HEALTH AND AGING-12112N01AG012112 · NIA · JOHNS HOPKINS UNIVERSITY · 1991 to 2003
$500k
Intramural NIH HHSNIA NIH HHS K23 AG019161NIA NIH HHS K23 AG19161NIA NIH HHS N01-AG-1-2112NIA NIH HHS P30 AG028747NIA NIH HHS R37 AG009901NIA NIH HHS R37 AG019905NIA NIH HHS R37-AG19905
6 · The paper itself

Abstract

unlabelledHormone levels were compared over a 1-year period between elderly women who had sustained a hip fracture and women of similar age and functional ability. Our study suggests progressive hormonal changes that may contribute to severe bone loss during the year following hip fracture.

introductionAlterations in hormones affecting the musculoskeletal system may increase risk of hip fracture or poor post-fracture recovery in postmenopausal women. Most studies lack appropriate reference groups, and thus cannot assess the extent to which these alterations are attributable to hip fracture.

methodsWomen aged ≥65 years hospitalized for an acute hip fracture (Baltimore Hip Studies, BHS-3; n = 162) were age-matched to 324 women enrolled in the Women's Health and Aging Study I, a Baltimore-based cohort with similar functional status to the pre-fracture status of BHS-3 women. Both studies enrolled participants from 1992 to 1995. Insulin-like growth hormone-1 (IGF-1), parathyroid hormone (PTH), 1,25 dihydroxyvitamin D [1,25(OH)2D], and osteocalcin were evaluated at baseline and 2, 6, and 12 months post-fracture, and at baseline and 12 months in the comparison group. Between-group differences in trajectories of each hormone were examined.

resultsBaseline mean IGF-1 levels were significantly lower in hip fracture patients than the comparison group (75.0 vs. 110.5 μg/dL; p < 0.001). Levels increased by 2 months post-fracture, but remained significantly lower than those in the comparison group throughout the 12-month follow-up (p < 0.01). Levels of PTH and osteocalcin were similar between groups at baseline, but rose during the year post-fracture to significantly differ from the comparison women (p < 0.001). 1,25(OH)2D levels did not differ between the hip fracture and comparison women at any time.

conclusionsOlder women who have sustained a hip fracture have progressive changes in hormonal milieu that exceed those of women of similar health status during the year following fracture.

Indexed as

25-Hydroxyvitamin D 2AgedAged, 80 and overCase-Control StudiesFemaleFollow-Up StudiesHip FracturesHormonesHumansInsulin-Like Growth Factor IOsteocalcinOsteoporotic FracturesParathyroid Hormone25-Hydroxyvitamin D 2HormonesInsulin-Like Growth Factor IOsteocalcinParathyroid Hormone

Identifiers

PMID20204599
PMCPMC2916079
OpenAlexW2079399651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.